New study aims to predict chemo risks for seniors with cancer
NCT ID NCT07151794
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether three easy-to-use health checklists (G8, CARG, and Frailty scales) can predict chemotherapy side effects in people aged 65 and older with solid tumors. Researchers will also check if these scores relate to nutrition blood tests and the need for a drug called G-CSF. The goal is to help doctors personalize treatment and reduce harm in older patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict which older cancer patients are at higher risk for chemotherapy side effects, allowing for safer, more personalized treatment plans.
- What could go wrong
- This is an observational study, not testing a new treatment. The results may not apply to all patients or lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERIATRIC ONCOLOGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Çanakkale Onsekiz Mart Univercity
Çanakkale, 17020, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can cooling after cardiac arrest change how the body burns fuel?
- Could a breathing exercise and music tame cancer treatment fatigue?
- Can tailored nutrition boost recovery in the ICU?
- Prescribing food: could a diet of medically tailored meals tame diabetes?
- Could a simple diet beat metabolic syndrome? genes may hold the key
- Fasting in the ICU: a metabolic key to immune response?